Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
ACS Applied Nano Materials|April 17, 2025
Extracellular Vesicle-Liposome-Darunavir Formulation for the Treatment of HIV NeuropathogenesisLina Zhou, Sandip Godse, Namita Sinha, et al.Molecular Pharmaceutics|November 20, 2019
Synthesis and Characterization of Long-Acting Darunavir ProdrugsMary G Banoub, Aditya N Bade, Zhiyi Lin, et al.Nature Communications|September 17, 2021
Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profilesDenise A Cobb, Nathan Smith, Suyash Deodhar, et al.Frontiers in Pharmacology|November 14, 2025
CEST MRI detects antiretroviral drug toxicities in the developing mouse brainMicah Summerlin, Mariano G Uberti, Dhananjay Shinde, et al.International Journal of Nanomedicine|September 10, 2019
Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulationIbrahim M Ibrahim, Aditya N Bade, Zhiyi Lin, et al.Biomaterials|September 17, 2019
A long acting nanoformulated lamivudine ProTideNathan Smith, Aditya N Bade, Dhruvkumar Soni, et al.Biomaterials|September 1, 2019
Synthesis of a long acting nanoformulated emtricitabine ProTideDhruvkumar Soni, Aditya N Bade, Nagsen Gautam, et al.Nature Communications|February 7, 2018
Creation of a long-acting nanoformulated dolutegravirBrady Sillman, Aditya N Bade, Prasanta K Dash, et al.The Journal of Clinical Investigation|January 31, 2017
Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugsDivya Prakash Gnanadhas, Prasanta K Dash, Brady Sillman, et al.Nature Communications|June 9, 2021
Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravirNagsen Gautam, JoEllyn M McMillan, Devendra Kumar, et al.Pageof 6